“…In the present study, these respective rates were 21.6% and 20.0%, which provides confidence in the reliability of the two studies. During the same period, Oda et al [25] conducted an epidemiological survey of ALI/ARDS in Chiba Prefecture, and found an annual incidence of ALI/ARDS of 6.1/100,000 population and a 28-day mortality rate of 31.6%. These findings suggest that the mortality rates of ALI/ARDS patients are lower in the Tohoku district and Chiba Prefecture in Japan compared to the findings of studies in the United States and Europe [9,10,12,13,23,24].…”